BioCentury
ARTICLE | Clinical News

Antineoplastons: Phase II data

June 1, 2009 7:00 AM UTC

Data from a Japanese Phase II trial in 65 MCRC patients who had undergone curative resection of hepatic metastases showed that Antineoplastons (ANP) therapy in combination with 5-fluorouracil (5-FU) p...